<DOC>
	<DOCNO>NCT00435747</DOCNO>
	<brief_summary>The present study aim compare pre-emptive analgesic efficacy parecoxib 40 mg IV/IM versus placebo reduce postoperative acute pain follow submuscular breast augmentation . Additionally study conducted evaluate safety tolerability parecoxib kind procedure .</brief_summary>
	<brief_title>Efficacy And Safety Of Parecoxib IV/IM 40 Mg Vs Placebo Following Sub Muscular Breast Augmentation</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Parecoxib</mesh_term>
	<criteria>Female patient ethnic origin age 18 year . The patient postmenopausal , surgically sterile , use adequate contraception , lactating , negative urine pregnancy test screening , prior administration study medication . The patient 's preoperative health grade class I II accord ASA physical status classification basis medical history physical examination . The patient significant clinical sign symptom suggestive renal hepatic morbid condition The patient history clinically significant hypersensitivity NSAIDs , cyclooxygenase inhibitor , analgesic sulfa medication cross sensitivity medication use study . The patient use analgesic agent ( antidepressant , sedate antihistamine sedative , muscle relaxant , narcotic , corticosteroid ) four hour precede procedure could confound analgesic response . Subjects history establish ischemic heart disease ( e.g . myocardial infarction , stable angina , unstable angina ) , peripheral arterial disease and/or cerebrovascular disease ( e.g . ischemic hemorrhagic stroke , transient ischemic attack ) , well subject previous revascularization procedure coronary , carotid , cerebral , renal , aortic peripheral arterial vasculature</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>